Thu, November 18, 2021
Wed, November 17, 2021
Tue, November 16, 2021
Mon, November 15, 2021
Fri, November 12, 2021
Thu, November 11, 2021
Wed, November 10, 2021

Joseph Schwartz Maintained (ASND) at Buy with Increased Target to $190 on, Nov 15th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-190-on-nov-15th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Joseph Schwartz of SVB Leerink, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $182 to $190 on, Nov 15th, 2021.

Joseph has made no other calls on ASND in the last 4 months.



There are 3 other peers that have a rating on ASND. Out of the 3 peers that are also analyzing ASND, 1 agrees with Joseph's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tazeen Ahmad of "B of A Securities" Downgraded from Strong Buy to Hold and Increased Target to $169 on, Wednesday, October 20th, 2021


These are the ratings of the 2 analyists that currently disagree with Joseph


  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $179 on, Thursday, November 11th, 2021
  • David Lebowitz of "Morgan Stanley" Maintained at Buy with Increased Target to $204 on, Thursday, August 26th, 2021

Publication Contributing Sources